{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:55:55Z","timestamp":1788796555630,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10549-013-2577-z","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T04:13:04Z","timestamp":1370578384000},"page":"657-665","source":"Crossref","is-referenced-by-count":16,"title":["T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity"],"prefix":"10.1007","volume":"139","author":[{"given":"Denise L.","family":"Cecil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekram","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen M.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Plymate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Disis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,8]]},"reference":[{"key":"2577_CR1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1517\/14712598.2011.616889","volume":"11","author":"AK Sears","year":"2011","unstructured":"Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE (2011) AE37: a novel T-cell-eliciting vaccine for breast cancer. Expert Opin Biol Ther 11:1543\u20131550","journal-title":"Expert Opin Biol Ther"},{"key":"2577_CR2","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1200\/JCO.2008.20.6789","volume":"27","author":"ML Disis","year":"2009","unstructured":"Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG (2009) Concurrent trastuzumab and HER2\/neu-specific vaccination in patients with metastatic breast cancer. J Clin Oncol 27:4685\u20134692","journal-title":"J Clin Oncol"},{"key":"2577_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-011-1529-8","volume":"132","author":"R Yerushalmi","year":"2012","unstructured":"Yerushalmi R, Gelmon KA, Leung S, Gao D, Cheang M, Pollak M, Turashvili G, Gilks BC, Kennecke H (2012) Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes. Breast Cancer Res Treat 132:131\u2013142","journal-title":"Breast Cancer Res Treat"},{"key":"2577_CR4","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","volume":"68","author":"JH Law","year":"2008","unstructured":"Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE (2008) Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res 68:10238\u201310246","journal-title":"Cancer Res"},{"key":"2577_CR5","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/1078-0432.CCR-10-1903","volume":"17","author":"BC Litzenburger","year":"2011","unstructured":"Litzenburger BC, Creighton CJ, Tsimelzon A, Chan BT, Hilsenbeck SG, Wang T, Carboni JM, Gottardis MM, Huang F, Chang JC, Lewis MT, Rimawi MF, Lee AV (2011) High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy. Clin Cancer Res 17:2314\u20132327","journal-title":"Clin Cancer Res"},{"key":"2577_CR6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","volume":"314","author":"A Lanzavecchia","year":"1985","unstructured":"Lanzavecchia A (1985) Antigen-specific interaction between T and B cells. Nature 314:537\u2013539","journal-title":"Nature"},{"key":"2577_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.coi.2010.09.008","volume":"23","author":"Y Ma","year":"2011","unstructured":"Ma Y, Aymeric L, Locher C, Kroemer G, Zitvogel L (2011) The dendritic cell-tumor cross-talk in cancer. Curr Opin Immunol 23:146\u2013152","journal-title":"Curr Opin Immunol"},{"key":"2577_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jim.2005.09.011","volume":"308","author":"ML Disis","year":"2006","unstructured":"Disis ML, dela Rosa C, Goodell V, Kuan LY, Chang JC, Kuus-Reichel K, Clay TM, Kim Lyerly H, Bhatia S, Ghanekar SA, Maino VC, Maecker HT (2006) Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods 308:13\u201318","journal-title":"J Immunol Methods"},{"key":"2577_CR9","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1158\/0008-5472.CAN-07-5891","volume":"68","author":"KH Park","year":"2008","unstructured":"Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML (2008) Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer. Cancer Res 68:8400\u20138409","journal-title":"Cancer Res"},{"key":"2577_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2172-9-23","volume":"9","author":"V Goodell","year":"2008","unstructured":"Goodell V, McNeel D, Disis ML (2008) His-tag ELISA for the detection of humoral tumor-specific immunity. BMC Immunol 9:23","journal-title":"BMC Immunol"},{"key":"2577_CR11","doi-asserted-by":"crossref","first-page":"e5013","DOI":"10.1371\/journal.pone.0005013","volume":"4","author":"D Ramduth","year":"2009","unstructured":"Ramduth D, Day CL, Thobakgale CF, Mkhwanazi NP, de Pierres C, Reddy S, van der Stok M, Mncube Z, Nair K, Moodley ES, Kaufmann DE, Streeck H, Coovadia HM, Kiepiela P, Goulder PJ, Walker BD (2009) Immunodominant HIV-1 Cd4\u00a0+\u00a0T cell epitopes in chronic untreated clade C HIV-1 infection. PLoS ONE 4:e5013","journal-title":"PLoS ONE"},{"key":"2577_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(03)00240-0","volume":"279","author":"RE Guerkov","year":"2003","unstructured":"Guerkov RE, Targoni OS, Kreher CR, Boehm BO, Herrera MT, Tary-Lehmann M, Lehmann PV, Schwander SK (2003) Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J Immunol Methods 279:111\u2013121","journal-title":"J Immunol Methods"},{"key":"2577_CR13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.178.5.1473","volume":"178","author":"AC Fluckiger","year":"1993","unstructured":"Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J (1993) Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 178:1473\u20131481","journal-title":"J Exp Med"},{"key":"2577_CR14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","volume":"89","author":"F Rousset","year":"1992","unstructured":"Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890\u20131893","journal-title":"Proc Natl Acad Sci USA"},{"key":"2577_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80533-6","volume":"8","author":"A O\u2019Garra","year":"1998","unstructured":"O\u2019Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275\u2013283","journal-title":"Immunity"},{"key":"2577_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000213183","volume":"36","author":"A Ruffatti","year":"1990","unstructured":"Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, Todesco S (1990) Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 36:104\u2013111","journal-title":"Gerontology"},{"key":"2577_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2249.2001.01454.x","volume":"123","author":"R Attanasio","year":"2001","unstructured":"Attanasio R, Brasky KM, Robbins SH, Jayashankar L, Nash RJ, Butler TM (2001) Age-related autoantibody production in a nonhuman primate model. Clin Exp Immunol 123:361\u2013365","journal-title":"Clin Exp Immunol"},{"key":"2577_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.2008.03709.x","volume":"153","author":"S Tachikawa","year":"2008","unstructured":"Tachikawa S, Kawamura T, Kawamura H, Kanda Y, Fujii Y, Matsumoto H, Abo T (2008) Appearance of B220low autoantibody-producing B-1 cells at neonatal and older stages in mice. Clin Exp Immunol 153:448\u2013455","journal-title":"Clin Exp Immunol"},{"key":"2577_CR19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/dmrr.2302","volume":"28","author":"A Viardot","year":"2012","unstructured":"Viardot A, Heilbronn LK, Samocha-Bonet D, Mackay F, Campbell LV, Samaras K (2012) Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev 28:447\u2013454","journal-title":"Diabetes Metab Res Rev"},{"key":"2577_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ghir.2008.06.004","volume":"19","author":"KAH B\u00e4ck","year":"2009","unstructured":"B\u00e4ck KAH (2009) Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm IGF Res 19:101\u2013111","journal-title":"Growth Horm IGF Res"},{"key":"2577_CR21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/1535-7163.MCT-07-0386","volume":"7","author":"V Goodell","year":"2008","unstructured":"Goodell V, Waisman J, Salazar LG, de la Rosa C, Link J, Coveler AL, Childs JS, Fintak PA, Higgins DM, Disis ML (2008) Level of HER-2\/neu protein expression in breast cancer may affect the development of endogenous HER-2\/neu-specific immunity. Mol Cancer Ther 7:449\u2013454","journal-title":"Mol Cancer Ther"},{"key":"2577_CR22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4049\/jimmunol.154.3.1177","volume":"154","author":"CM Snapper","year":"1995","unstructured":"Snapper CM, Kehry MR, Castle BE, Mond JJ (1995) Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy. J Immunol 154:1177\u20131187","journal-title":"J Immunol"},{"key":"2577_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr1746","volume":"9","author":"DG DeNardo","year":"2007","unstructured":"DeNardo DG, Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9:212","journal-title":"Breast Cancer Res"},{"key":"2577_CR24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20061120","volume":"204","author":"C Aspord","year":"2007","unstructured":"Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, Marches F, Banchereau J, Palucka AK (2007) Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4\u00a0+\u00a0T cells that facilitate tumor development. J Exp Med 204:1037\u20131047","journal-title":"J Exp Med"},{"key":"2577_CR25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20102131","volume":"208","author":"A Pedroza-Gonzalez","year":"2011","unstructured":"Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK (2011) Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med 208:479\u2013490","journal-title":"J Exp Med"},{"key":"2577_CR26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00262-004-0556-2","volume":"53","author":"I Caras","year":"2004","unstructured":"Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother 53:1146\u20131152","journal-title":"Cancer Immunol Immunother"},{"key":"2577_CR27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","volume":"60","author":"RF Gabitass","year":"2011","unstructured":"Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 60:1419\u20131430","journal-title":"Cancer Immunol Immunother"},{"issue":"652\u2013658","key":"2577_CR28","first-page":"e651","volume":"121","author":"T Akkoc","year":"2008","unstructured":"Akkoc T, de Koning PJ, Ruckert B, Barlan I, Akdis M, Akdis CA (2008) Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol 121(652\u2013658):e651","journal-title":"J Allergy Clin Immunol"},{"key":"2577_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"2577_CR30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.00-0372com","volume":"15","author":"N Ilan","year":"2001","unstructured":"Ilan N, Mohsenin A, Cheung L, Madri JA (2001) PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 15:362\u2013372","journal-title":"FASEB J"},{"key":"2577_CR31","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI31990","volume":"117","author":"Y Miyake","year":"2007","unstructured":"Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M (2007) Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest 117:2268\u20132278","journal-title":"J Clin Invest"},{"key":"2577_CR32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3858\/emm.2008.40.1.130","volume":"40","author":"TJ Yoon","year":"2008","unstructured":"Yoon TJ, Kim JY, Kim H, Hong C, Lee H, Lee CK, Lee KH, Hong S, Park SH (2008) Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp Mol Med 40:130\u2013144","journal-title":"Exp Mol Med"},{"key":"2577_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209\u2013223","journal-title":"Immunity"},{"key":"2577_CR34","doi-asserted-by":"crossref","first-page":"e23651","DOI":"10.1371\/journal.pone.0023651","volume":"6","author":"T Tsuji","year":"2011","unstructured":"Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S (2011) Split T cell tolerance against a self\/tumor antigen: spontaneous CD4\u00a0+\u00a0but not CD8\u00a0+\u00a0T cell responses against p53 in cancer patients and healthy donors. PLoS ONE 6:e23651","journal-title":"PLoS ONE"},{"key":"2577_CR35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cellimm.2012.01.001","volume":"273","author":"L Alvarez-Rodriguez","year":"2012","unstructured":"Alvarez-Rodriguez L, Lopez-Hoyos M, Munoz-Cacho P, Martinez-Taboada VM (2012) Aging is associated with circulating cytokine dysregulation. Cell Immunol 273:124\u2013132","journal-title":"Cell Immunol"},{"key":"2577_CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2249.2000.01224.x","volume":"120","author":"S Sakata-Kaneko","year":"2000","unstructured":"Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T (2000) Altered Th1\/Th2 commitment in human CD4\u00a0+\u00a0T cells with ageing. Clin Exp Immunol 120:267\u2013273","journal-title":"Clin Exp Immunol"},{"key":"2577_CR37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/oby.2010.1","volume":"18","author":"KJ Strissel","year":"2010","unstructured":"Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS (2010) T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL\/6 mice. Obesity (Silver Spring) 18:1918\u20131925","journal-title":"Obesity (Silver Spring)"},{"key":"2577_CR38","first-page":"R1898","volume":"275","author":"BG Marques","year":"1998","unstructured":"Marques BG, Hausman DB, Martin RJ (1998) Association of fat cell size and paracrine growth factors in development of hyperplastic obesity. Am J Physiol 275:R1898\u2013R1908","journal-title":"Am J Physiol"},{"key":"2577_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1467-789X.2001.00042.x","volume":"2","author":"DB Hausman","year":"2001","unstructured":"Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ (2001) The biology of white adipocyte proliferation. Obes Rev 2:239\u2013254","journal-title":"Obes Rev"},{"key":"2577_CR40","first-page":"1019","volume":"8","author":"SH Burg van der","year":"2002","unstructured":"van der Burg SH, Menon AG, Redeker A, Bonnet MC, Drijfhout JW, Tollenaar RA, van de Velde CJ, Moingeon P, Kuppen PJ, Offringa R, Melief CJ (2002) Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine. Clin Cancer Res 8:1019\u20131027","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2577-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2577-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T07:34:19Z","timestamp":1688283259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2577-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2577"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2577-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}